# Pfizer Inc. (PFE) — Q3-2016 Earnings Results

**Report date:** 2016-11-01 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q3-2016

## Post-Earnings Brief

### Headline

Pfizer Misses on EPS, Stock Down 2.02%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.61 | N/A | -1.61% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Defensive

Management acknowledged the difficulties faced in the current market environment. They did not offer any updates on future performance expectations.

**Key quotes:**

> Management expressed concerns about market conditions affecting performance.

> They highlighted ongoing challenges in product sales.

> No specific guidance was provided for future quarters.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Pfizer's earnings report indicates a slight miss on EPS, which contributed to a 2.02% decline in stock price. The lack of revenue data and guidance may raise concerns among investors about the company's future performance. The defensive tone from management suggests they are cautious about market conditions moving forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q3-2016_